AI is accelerating drug discovery at an unprecedented pace. Thousands of antibody candidates can now be designed in silico ...
RNA therapeutics are expanding rapidly, driving demand for manufacturing processes that can keep pace with clinical translation. Because mRNA yield and impurity profiles are jointly influenced by ...
YMC’s HPLC (high-performance liquid chromatography) columns/packing materials are considered high-quality products with a good track record worldwide. The company provides reversed-phase UHPLC/HPLC ...
SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced the release of its next generation Agilent InfinityLab LC Series portfolio, which includes the 1290 Infinity ...
Researchers from Bristol Myers Squibb and Sanofi recently tested a new means of using hydrophobic interaction chromatography (HIC) for removing impurities in monoclonal antibodies (mAbs). Scientists ...
1 Department of Chemistry, Sikkim Professional University, Gangtok, India. 2 Analytical Research & Development, Hikma Pharmaceuticals USA Inc., Bedford, USA. 3 ...
Antibody-drug conjugates (ADCs) are dual-action cancer biotherapeutics, where monoclonal antibodies carrying tumor-killing payloads specifically bind to cancer cells and accelerate cancer cell death.
A prominent Southeastern developer and a national homebuilder have partnered on a massive 20-year live-work-play project on 2,600 acres in South Carolina. HIC Land bought the Hardeeville property — ...
High-performance liquid chromatography-mass spectrometry (HPLC-MS) combines the separation power of LC with the detection specificity of MS. It has become an indispensable analytical tool in the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results